OS Therapies
OSTX | AMEX
$0.68
-$0.06 (-8.72%)
At close: Nov 16, 2026, 4:00 PM ET
$0.68
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:55 PM ET
-8.72%
(1D)No price chart data available for 1D timeframe.
Rating
21
-9.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #984/1021 (Top 96%)
Key Statistics
Market Data
Market Cap $31.86M
1D Range
0.67 0.75
52W Range
0.67 2.24
Valuation (TTM)
PE -0.62
PB -0.00
EV/EBITDA N/A
Valuation (NTM)
Forward PE N/A
Forward PEG -0.10
Price Target $16.50
Cash Flow
FCF Yield -58.2%
SBC Adj. FCF Yield -69.4%
SBC Impact -19.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -58.0% |
-30.8%
FCF 3Y | 5Y -67.7% |
-35.3%
Returns
ROA -0.4%
ROE 1.3%
ROIC 0.3%
Financial Health
Net Cash
$205.04M
Current Ratio 0.18
Interest Coverage -464.76
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the Un...
Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Aug 1, 2024
Website ostherapies.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$16.50
Upside
+2326.47%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove OSTX